| European Case Law Identifier: | ECLI:EP:BA:2007:T177206.20071016 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 October 2007 | ||||||||
| Case number: | T 1772/06 | ||||||||
| Application number: | 97934319.1 | ||||||||
| IPC class: | C07H 17/08 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Preparation of crystal form II of clarithromycin | ||||||||
| Applicant name: | ABBOTT LABORATORIES | ||||||||
| Opponent name: | Sandoz AG Ranbaxy(UK) Ltd. Hexal AG Stada-Arzneimittel Aktiengesellschaft Ratiopharm GmbH NORTON HEALTHCARE LTD Teva Pharmaceutical Industries Ltd. Grünenthal GmbH |
||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Added matter (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t061772eu1.html
Date retrieved: 17 May 2021